Literature DB >> 21863228

Is routine cholecystectomy justified in severely obese patients undergoing a laparoscopic Roux-en-Y gastric bypass procedure? A comparative cohort study.

Ignazio Tarantino1, Renè Warschkow, Thomas Steffen, Philipp Bisang, Bernd Schultes, Martin Thurnheer.   

Abstract

BACKGROUND: The aim of the present study was to evaluate the risks and benefits of concurrent prophylactic cholecystectomy (CPC) during laparoscopic Roux-en-Y gastric bypass (LRYGB).
METHODS: From December 2000 to November 2006, CPC during LRYGB was only performed in the presence of gallbladder pathology (n = 140). Beginning in December 2006, CPC was performed during all LRYGB procedures (n = 134). Exclusion criteria were open bypass procedure, previous bariatric surgery other than gastric banding, and previous cholecystectomy (CCE) or necessary concurrent CCE due to gallbladder pathology.
RESULTS: During a median follow-up of 3.1 years, 26 (18.6%; 95% CI, 12.9-25.9%) of 140 patients without CPC subsequently required a CCE, leading to a gallbladder disease-free survival rate at 5 years of 77.4% (95% CI, 67.3-87.6%). Multivariate analysis identified a distal LRYGB and excess weight loss of >75% at 2 years to be significant risk factors for the development of biliary complications while a preoperative BMI > 50 m(2)/kg was protective. In the second series, prophylactic CCE was not associated with prolonged hospitalization or operative time. The postoperative complications were not related to the CPC.
CONCLUSIONS: The present data indicate that a substantial number of patients develop gallbladder complications after LRYGB. Furthermore, CPC can safely be performed during LRYGB. Based on these findings, CPC should be considered a reasonable approach in severely obese patients undergoing LRYGB.

Entities:  

Mesh:

Year:  2011        PMID: 21863228     DOI: 10.1007/s11695-011-0495-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  34 in total

1.  Is routine cholecystectomy necessary at the time of Roux-en-Y gastric bypass?

Authors:  Jerome Taylor; I Michael Leitman; Michael Horowitz
Journal:  Obes Surg       Date:  2006-06       Impact factor: 4.129

2.  The case for prophylactic cholecystectomy concomitant with gastric restriction for morbid obesity.

Authors:  J H Schmidt; M P Hocking; W R Rout; E R Woodward
Journal:  Am Surg       Date:  1988-05       Impact factor: 0.688

3.  Massive subcutaneous emphysema after attempted endoscopic retrograde cholangiopancreatography in a patient with a history of bariatric gastric bypass surgery.

Authors:  P Mosler; E L Fogel
Journal:  Endoscopy       Date:  2007-07-23       Impact factor: 10.093

4.  Cholecystectomy during laparoscopic gastric bypass has no effect on duration of hospital stay.

Authors:  Ahmed R Ahmed; William O'Malley; Joseph Johnson; Thad Boss
Journal:  Obes Surg       Date:  2007-08       Impact factor: 4.129

5.  Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.

Authors:  L James Wudel; J Kelly Wright; Jacob P Debelak; Tara M Allos; Yu Shyr; William C Chapman
Journal:  J Surg Res       Date:  2002-01       Impact factor: 2.192

6.  Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients?

Authors:  Daniel E Swartz; Edward L Felix
Journal:  Surg Obes Relat Dis       Date:  2005-09-28       Impact factor: 4.734

7.  Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary?

Authors:  Joseph A Caruana; Marc N McCabe; Audrey D Smith; Daniel Sette Camara; Michele A Mercer; John A Gillespie
Journal:  Surg Obes Relat Dis       Date:  2005 Nov-Dec       Impact factor: 4.734

8.  Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity.

Authors:  M L Shiffman; H J Sugerman; J M Kellum; W H Brewer; E W Moore
Journal:  Am J Gastroenterol       Date:  1991-08       Impact factor: 10.864

9.  Gallstones in patients with morbid obesity. Relationship to body weight, weight loss and gallbladder bile cholesterol solubility.

Authors:  M L Shiffman; H J Sugerman; J H Kellum; W H Brewer; E W Moore
Journal:  Int J Obes Relat Metab Disord       Date:  1993-03

10.  Is routine cholecystectomy required during laparoscopic gastric bypass?

Authors:  Leonardo Villegas; Benjamin Schneider; David Provost; Craig Chang; Daniel Scott; Thomas Sims; Lois Hill; Linda Hynan; Daniel Jones
Journal:  Obes Surg       Date:  2004-02       Impact factor: 4.129

View more
  15 in total

Review 1.  Concomitant cholecystectomy during laparoscopic Roux-en-Y gastric bypass in obese patients is not justified: a meta-analysis.

Authors:  Rene Warschkow; Ignazio Tarantino; Kristjan Ukegjini; Ulrich Beutner; Ulrich Güller; Bruno M Schmied; Sascha A Müller; Bernd Schultes; Martin Thurnheer
Journal:  Obes Surg       Date:  2013-03       Impact factor: 4.129

2.  Cholecystectomy in Patients Submitted to Bariatric Procedure: A Systematic Review and Meta-analysis.

Authors:  Francisco Tustumi; Wanderley M Bernardo; Marco A Santo; Ivan Cecconello
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

3.  Factors Affecting the Development of Gallstones Following Laparoscopic Sleeve Gastrectomy.

Authors:  Sabri Özdaş; Hilmi Bozkurt
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

4.  A Prospective Study of the Conservative Management of Asymptomatic Preoperative and Postoperative Gallbladder Disease in Bariatric Surgery.

Authors:  Omar Pineda; Hernán G Maydón; Mónica Amado; Elisa M Sepúlveda; Lizbeth Guilbert; Omar Espinosa; Carlos Zerrweck
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

5.  Potential Benefits of Prophylactic Cholecystectomy in Patients Undergoing Bariatric Bypass Surgery.

Authors:  Sébastien Amstutz; Jean-Marie Michel; Sébastien Kopp; Bernhard Egger
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

6.  Analysis of the Management of Cholelithiasis in Bariatric Surgery Patients: a Single-Center Experience.

Authors:  Carlos Gustavo Petrola Chacón; Ramón Vilallonga; Óscar González López; Amador García Ruiz de Gordejuela; Marc Beisani; Enric Caubet Busquet; Jose Manuel Fort; Manel Armengol Carrasco
Journal:  Obes Surg       Date:  2022-01-04       Impact factor: 4.129

7.  Concomitant cholecystectomy during laparoscopic sleeve gastrectomy.

Authors:  Asnat Raziel; Nasser Sakran; Amir Szold; David Goitein
Journal:  Surg Endosc       Date:  2014-12-06       Impact factor: 4.584

8.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

9.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Endocr Pract       Date:  2013 Mar-Apr       Impact factor: 3.443

10.  Influence of Insulin Resistance Status on the Development of Gallstones Following Roux-En-Y Gastric Bypass: a Prospective Cohort Study.

Authors:  Everton Cazzo; Martinho Antonio Gestic; Murillo Pimentel Utrini; Ricardo Rossetto Machado; Laísa Simakawa Jimenez; Amanda Pinter Carvalheiro da Silva; Jamal Baracat; Francisco Callejas-Neto; José Carlos Pareja; Elinton Adami Chaim
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.